MediciGlobal Wins Communications Awards for Patient Recruitment and Retention
MediciGlobal Wins Four International 2009 Communications Awards for Patient Recruitment and Retention
PHILADELPHIA and LONDON, June 17 /PRNewswire/ -- MediciGlobal, a leading speciality patient recruitment-retention company, receives four separate Awards of Distinction in The 2009 Communicator Awards from the International Academy of the Visual Arts. The Communicator Awards is the leading international awards program honouring creative excellence for Communications Professionals.
MediciGlobal won awards on behalf of three global pharmaceutical clients in four distinct disease areas:
Depression Promotional Study Site Kit
Menopause Promotional Study Site Kit
Clinically Isolated Syndrome Patient Education Programme
(Pre-diagnosed Multiple Sclerosis)
Teen Migraine Patient Recruitment Campaign
"We know the importance of developing high quality programmes that adhere to health literacy guidelines," says Liz Moench, MediciGlobal's President and CEO. "Study sites rightly expect materials of high quality to hand to their patients," adds Moench.
MediciGlobal knows that recruitment and retention materials are most effective when study researchers and their clinical coordinators are proud to use them, and when patients value the information they provide about clinical trial participation.
Since 2007, the company has received 10 national and international awards for its patient recruitment and retention programmes. These awards recognise MediciGlobal's work in support of CNS, endocrinology, oncology, and infectious disease clinical trials. "Receiving recognition such as this, further attests that our programmes are innovative, patient-friendly and industry-leading," notes Liz Moench.
Winners for the 2009 awards were chosen from over 9,000 world-wide entries, and were judged by the International Academy of the Visual Arts, an invitation-only professional organization consisting of top-tier professionals from leading media, communications, advertising, and marketing firms.
About MediciGlobal
MediciGlobal based in the U.S. and U.K., is a specialty patient recruitment - retention company, developing patient-centric programmes for clinical trials of all sizes, and in countries around the globe. MediciGlobal's patient recruitment and retention programmes ensure that biopharmaceutical and life sciences companies meet or exceed their clinical study timelines. MediciGlobal is one of few companies focused solely on patient recruitment and retention for almost two decades. www.mediciglobal.com.
About The Communicator Awards
The Communicator Awards is the leading international awards program honouring creative excellence for communications professionals. The Communicator Awards is an annual competition honouring the best in advertising, corporate communications, public relations and brand-identity work for print, video, interactive and audio. Visit www.communicatorawards.com for more information.
CONTACT: Lindsey Lewis of MediciGlobal, +1-484-674-6872, llewis@mediciglobal.com
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.
